Skip to content

Clinical trials

Inflammatory Bowel Diseases trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Not applicable Clear all

480 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20051
20062
20076
20087
200910
20108
20114
201213
201316
201415
201520
201622
201731
201826
201943
202024
202136
202232
202328
202444
202552
202632

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed207
Unknown status97
Recruiting68
Not yet recruiting36
Terminated27
Active, not recruiting21
Withdrawn13
Enrolling by invitation7
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital9
Mount Sinai Hospital, Canada7
Cedars-Sinai Medical Center6
Changhai Hospital6
McMaster University6
Stanford University6
University of Michigan6
Children's Hospital Medical Center, Cincinnati5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
Icahn School of Medicine at Mount Sinai5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases480
Crohn Disease191
Colitis, Ulcerative189
Irritable Bowel Syndrome16
Anxiety Disorders12
Colitis12
Fatigue11
Gastrointestinal Diseases11
Colorectal Neoplasms10
Inflammation10

Trials

Showing 51 to 75 of 480. Each trial links to its page on Pharma Observatory.

380 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.